The findings suggest that older patients with severe COVID-19 may respond more favorably to immunomodulatory therapies aimed at certain inflammatory cytokines, the authors say.
Severe COVID in older adults may be due to greater viral load, weaker immune response
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows